Tech Company Financing Transactions
Jenrin Discovery Funding Round
BioAdvance Ventures participated in a $500 thousand funding round for Jenrin Discovery. The round closed on 3/31/2005.
Transaction Overview
Company Name
Announced On
3/31/2005
Transaction Type
Venture Equity
Amount
$500,000
Round
Undisclosed
Investors
BioAdvance Ventures (Barbara Schilberg)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
285 Wilmington-West Chester Pike
Chadds Ford, PA 19317
USA
Chadds Ford, PA 19317
USA
Phone
Undisclosed
Website
Email Address
Overview
Jenrin Discovery, Inc. is a privately owned emerging pharmaceutical company focused on developing safer and more effective therapeutics for a variety of chronic diseases, including obesity, diabetes and autoimmune/inflammatory disorders.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Scientific Officer
Robert Chorvat
Browse more venture capital transactions:
Prev: 3/31/2005: SupplyFrame venture capital transaction
Next: 3/31/2005: UltraCell venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs